Bioavailability of Different n-3 Fatty Acid Formulations

Inclusion Criteria: * males, * 20-50 years, * Caucasian, * healthy, * body mass index (BMI) 20-28 kg/m², * no medical treatment, * written confirmation of the subjects after detailed spoken and written explanation about the study contents, * ability and willingness of the participants to attend the investigator's orders (compliance of the study conditions, consumption of the study drugs according to the dosage commendation Exclusion Criteria: * medical treatment (especially corticosteroids, anti-inflammatory drugs, blood lipids lowering drugs (e.g. statines, fibrates, bile acid exchanger resin, phytosterols) * taking any supplements with n-3 FAs, phytosterols, polyglucosamines (Chitosan) or other lipid binding ingredients * daily consumption of n-3 FAs rich fish (salmon, mackerel, herring) * heavy chronic diseases (tumors, diabetes typ 1, etc.), documented heart disease, documented blood clotting disorders, renal failure, liver diseases * documented blood clotting disorders and consumption of coagulation-inhibiting drugs (for example Marcumar, ASS) * allergy or intolerance to fish/fish oil or any of the study ingredients of the test products * chronic gastro-intestinal diseases (Colitis ulcerosa, Morbus Crohn, pancreatic insufficiency) * donation of blood in the last 6 weeks * routine consumption of laxative * alcohol-, drug- and/or medicament dependence * subjects who are not in agreement with the study conditions * refusal or rather reset of the consent from the subject * active participation in other investigational drug or device trial within the last 30 days